Inventor · disambiguated record
Michael Milburn
Also filed as: MILBURN MICHAEL · MILBURN MICHAEL V · MILBURN MICHAEL VANCE
17 granted patents·21 pending applications·385 citations·filing 2000–2022
94Inventor score
Top patents by PatentIndex Score
38 records- 0197US7572806B2PPAR active compoundsPLEXXIKON INC·Filed 2007·Granted Aug 11, 2009·59 cites·5 claims
- 0297US7348338B2PPAR active compoundsPLEXXIKON INC·Filed 2004·Granted Mar 25, 2008·79 cites·9 claims
- 0396US8367828B2PPAR active compoundsPLEXXIKON INC·Filed 2010·Granted Feb 5, 2013·54 cites·7 claims
- 0495US8187830B2Method for determining insulin sensitivity with biomarkersHU YUN FU·Filed 2008·Granted May 29, 2012·75 cites·12 claims
- 0595US7202266B2PPAR active compoundsPLEXXIKON INC·Filed 2004·Granted Apr 10, 2007·65 cites·54 claims
- 0686US6506781B1Oxazole PPAR antagonistSMITHKLINE BEECHAM CORP·Filed 2000·Granted Jan 14, 2003·32 cites·7 claims
- 0784US10267777B2Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessmentMETABOLON INC·Filed 2016·Granted Apr 23, 2019·4 cites·30 claims
- 0878US8546098B2Biomarkers for monitoring insulin resistance and methods using the sameHU YUN FU·Filed 2012·Granted Oct 1, 2013·3 cites·11 claims
- 0975US7998974B2Fused heterocyclic compounds and their use as sirtuin modulatorsSIRTRIS PHARMACEUTICALS INC·Filed 2006·Granted Aug 16, 2011·2 cites·16 claims
- 1074US12320798B2Diagnostic methods, therapeutic agents and uses thereofMETABOLON INC·Filed 2021·Granted Jun 3, 2025·0 cites·12 claims
- 1170US10502729B2Diagnostic methods, therapeutic agents and uses thereofMETABOLON INC·Filed 2016·Granted Dec 10, 2019·1 cites·6 claims
- 1270US8849577B2Methods of identifying biochemical pathwaysRYALS JOHN A·Filed 2007·Granted Sep 30, 2014·10 cites·102 claims
- 1367US2020110069A1Diagnostic methods, therapeutic agents and uses thereofMETABOLON INC·Filed 2019·Application pending·0 cites
- 1463US9250225B2Biomarkers for insulin resistance and methods using the sameHU YUN FU·Filed 2014·Granted Feb 2, 2016·0 cites·16 claims
- 1563US2015175645A1Nicotinamide riboside and analogues thereofGLAXOSMITHKLINE LLC·Filed 2014·Application pending·0 cites
- 1661US8809008B2Biomarkers for impaired glucose tolerance and methods using the sameHU YUN FU·Filed 2013·Granted Aug 19, 2014·0 cites·20 claims
- 1760US8658351B2Determining liver toxicity of an agent using metabolite biomarkersMILBURN MICHAEL·Filed 2010·Granted Feb 25, 2014·1 cites·15 claims
- 1858US2005048573A1PDE5A crystal structure and usesPLEXXIKON INC·Filed 2004·Application pending·0 cites
- 1956US10175233B2Biomarkers for cardiovascular diseases and methods using the sameMETABOLON INC·Filed 2015·Granted Jan 8, 2019·0 cites·8 claims
- 2054US2024182984A1Methods for assessing proliferation and anti-folate therapeutic responseGENECENTRIC THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2153US2006229265A1Nicotinamide riboside and analogues thereofSIRTRIS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2252US2020025729A1Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessmentMETABOLON INC·Filed 2019·Application pending·0 cites
- 2352US2014303228A1Biomarkers for Amyotrophic Lateral Sclerosis and Methods Using the SameMETABOLON INC·Filed 2012·Application pending·0 cites
- 2451US2004142864A1Crystal structure of PIM-1 kinasePLEXXIKON INC·Filed 2003·Application pending·0 cites
- 2550US2023243813A1Methods for selecting and treating cancer with fgfr3 inhibitorsGENECENTRIC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2649US2007149466A1Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disordersMILBURN MICHAEL·Filed 2006·Application pending·0 cites
- 2748US2006292099A1Treatment of eye disorders with sirtuin modulatorsMILBURN MICHAEL·Filed 2006·Application pending·0 cites
- 2846US2005170431A1PYK2 crystal structure and usesPLEXXIKON INC·Filed 2004·Application pending·0 cites
- 2944US2009163476A1N-Phenyl Benzamide Derivatives as Sirtuin ModulatorsSIRTRIS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3043US2009069301A1Acridine and Quinoline Derivatives as Sirtuin ModulatorsSIRTRIS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3142US2006276416A1Methods and compositions for treating flushing and drug induced weight gainSIRTRIS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3242US2004171062A1Methods for the design of molecular scaffolds and ligandsPLEXXIKON INC·Filed 2003·Application pending·0 cites
- 3341US2005079548A1Ligand development using PDE4B crystal structuresPLEXXIKON INC·Filed 2004·Application pending·0 cites
- 3440US2006276393A1Novel compositions for preventing and treating neurodegenerative and blood coagulation disordersSIRTRIS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3539US2007014833A1Treatment of eye disorders with sirtuin modulatorsSIRTRIS PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 3638US2012122981A1Biomarkers Related to Insulin Resistance and Methods using the SameHU YUN FU·Filed 2010·Application pending·0 cites
- 3735US2018314790A1System, Method and Apparatus for Determining the Effect of Genetic VariantsMETABOLON INC·Filed 2015·Application pending·0 cites
- 3833US9109252B2Identity elucidation of unknown metabolitesMILBURN MICHAEL·Filed 2012·Granted Aug 18, 2015·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Michael Milburn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →